Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter study
Journal of Gastroenterology · 2025-06 · 60 (6) · 727-737
DOI: 10.1007/s00535-025-02224-0 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Gastroenterology, online erschienen am 24.02.2025. Verfasst von Takashi Nishimura und 24 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hepatobiliary and Pancreatic Disease, Department of Gastroenterology, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya, Japan. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Fatty Liver. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canon Medical Systems Corporation.
Abstract (Originalsprache)
Background
Attenuation Imaging (ATI) and controlled attenuation parameter (CAP) are non-invasive ultrasound-based methods for diagnosing hepatic steatosis. However, reports on the clinical usefulness of ATI are limited. We aimed to compare the ability of ATI and CAP to diagnose hepatic steatosis with magnetic resonance imaging–based proton density fat fraction (MRI-PDFF) as the reference standard.
Methods
We performed a prospective multicenter study of 562 patients with chronic liver disease who underwent ATI, CAP, and MRI-PDFF. Patients with skin-to-liver capsule distance (SCD) ≤ 25 mm underwent CAP with an M probe; those with SCD > 25 mm underwent CAP with an XL probe. MRI-PDFF was used as the reference standard: S0 corresponds to MRI-PDFF < 5.2%, S1 to 5.2% ≤ MRI-PDFF < 11.3%, S2 to 11.3% ≤ MRI-PDFF < 17.1%, and S3 to MRI-PDFF ≥ 17.1%.
Results
The correlation coefficients for ATI and MRI-PDFF stratified by body mass index (< 30, ≥ 30 kg/m 2 ), SCD (< 25, ≥ 25 mm), 2-dimensional share wave elastography (< 1.8 m/s), fibrosis-4 index (≤ 2.67), albumin–bilirubin score (< − 2.60) and type IV collagen 7 s (< 5.0 ng/ml) were significantly higher than those for CAP and MRI-PDFF. Areas under the receiver operating characteristics (95% CI) for ATI and CAP were 0.895 (0.869–0.922) and 0.845 (0.809–0.881) for ≥ S1 steatosis, 0.944 (0.926–0.963) and 0.881(0.852–0.910) for ≥ S2 steatosis, and 0.928 (95% CI 0.906–0.950) and 0.860 (95% CI 0.829–0.890) for S3 steatosis. ATI had higher diagnostic performance for all hepatic steatosis grades than CAP.
Conclusions
ATI is a more useful non-invasive method for diagnosing hepatic steatosis than CAP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Hepatobiliary and Pancreatic Disease, Department of Gastroenterology, Hyogo Medical University, 1-1 Mukogawa-cho, Nishinomiya, Japan.
- Ultrasound Imaging Center, Hyogo Medical University Hospital, Nishinomiya, Japan.
- Department of Internal Medicine, Japanease Red Cross Himeji Hospital, Himeji, Japan.
- Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
- Department of Pathology, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
- Department of Gastroenterology, Nayoro City General Hospital, Nayoro, Japan.
Förderung
- Canon Medical Systems Corporation
Zitieren
APA
Nishimura, T., Tada, T., Akita, T., Kondo, R., Suzuki, Y., Imajo, K., Kokubu, S., Abe, T., Kuroda, H., Hirooka, M., Hiasa, Y., Nogami, A., Nakajima, A., Ogawa, S., Toyoda, H., Oeda, S., Takahashi, H., Eguchi, Y., Sugimoto, K., …, & Iijima, H. (2025). Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter study. Journal of Gastroenterology, 60(6), 727-737. https://doi.org/10.1007/s00535-025-02224-0
Vancouver
Nishimura T, Tada T, Akita T, Kondo R, Suzuki Y, Imajo K, et al. Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter study. Journal of Gastroenterology. 2025;60(6):727-737. doi:10.1007/s00535-025-02224-0
BibTeX
@article{Nishimura2025,
author = {Nishimura, Takashi and Tada, Toshifumi and Akita, Tomoyuki and Kondo, Reiichiro and Suzuki, Yasuaki and Imajo, Kento and Kokubu, Shigehiro and Abe, Tamami and Kuroda, Hidekatsu and Hirooka, Masashi and Hiasa, Yoichi and Nogami, Asako and Nakajima, Atsushi and Ogawa, Sadanobu and Toyoda, Hidenori and Oeda, Satoshi and Takahashi, Hirokazu and Eguchi, Yuichiro and Sugimoto, Katsutoshi and Yano, Hirohisa and Tanaka, Junko and Moriyasu, Fuminori and Kage, Masayoshi and Kumada, Takashi and Iijima, Hiroko},
title = {Diagnostic performance of attenuation imaging versus controlled attenuation parameter for hepatic steatosis with MRI-based proton density fat fraction as the reference standard: a prospective multicenter study},
journal = {Journal of Gastroenterology},
year = {2025},
volume = {60},
number = {6},
pages = {727--737},
doi = {10.1007/s00535-025-02224-0}
}
EUVIMED